These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31808996)

  • 1. Pragmatic Trials in Genomic Medicine: The Integrating Pharmacogenetics In Clinical Care (I-PICC) Study.
    Brunette CA; Miller SJ; Majahalme N; Hau C; MacMullen L; Advani S; Ludin SA; Zimolzak AJ; Vassy JL
    Clin Transl Sci; 2020 Mar; 13(2):381-390. PubMed ID: 31808996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Integrating Pharmacogenetics in Clinical Care (I-PICC) Study: Protocol for a point-of-care randomized controlled trial of statin pharmacogenetics in primary care.
    Vassy JL; Brunette CA; Majahalme N; Advani S; MacMullen L; Hau C; Zimolzak AJ; Miller SJ
    Contemp Clin Trials; 2018 Dec; 75():40-50. PubMed ID: 30367991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Delivering SLCO1B1 Pharmacogenetic Information in Randomized Trial and Observational Settings.
    Peyser B; Perry EP; Singh K; Gill RD; Mehan MR; Haga SB; Musty MD; Milazzo NA; Savard D; Li YJ; Trujilio G; Voora D
    Circ Genom Precis Med; 2018 Sep; 11(9):e002228. PubMed ID: 30354330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy.
    Ahangari N; Doosti M; Ghayour Mobarhan M; Sahebkar A; Ferns GA; Pasdar A
    Ann Med; 2020 Dec; 52(8):462-470. PubMed ID: 32735150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) model in clinical research: Application to refine a practice-based research network (PBRN) study.
    Elder WG; Munk N
    J Am Board Fam Med; 2014; 27(6):846-54. PubMed ID: 25381083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of
    Brunette CA; Vassy JL
    Pharmacogenomics; 2021 Jul; 22(11):649-656. PubMed ID: 34196599
    [No Abstract]   [Full Text] [Related]  

  • 7. Children Are Not Small Adults: Specific Findings in Statin Exposure and Response in a Growing Population.
    Wagner JB
    Clin Pharmacol Ther; 2019 Aug; 106(2):278-280. PubMed ID: 30970165
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol: A Randomized Clinical Trial.
    Vassy JL; Gaziano JM; Green RC; Ferguson RE; Advani S; Miller SJ; Chun S; Hage AK; Seo SJ; Majahalme N; MacMullen L; Zimolzak AJ; Brunette CA
    JAMA Netw Open; 2020 Dec; 3(12):e2027092. PubMed ID: 33270123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of SLCO1B1 Pharmacogenetic Testing on Patient and Healthcare Outcomes: A Systematic Review.
    Vassy JL; Chun S; Advani S; Ludin SA; Smith JG; Alligood EC
    Clin Pharmacol Ther; 2019 Aug; 106(2):360-373. PubMed ID: 30137643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease.
    Elchynski AL; Cicali EJ; Ferrer Del Busto MC; Hamilton A; Chang KL; Schmidt SO; Weiner B; Davis R; Estores D; Max Smith D; Wiisanen K; Johnson JA; Cavallari LH
    Pharmacogenomics J; 2021 Dec; 21(6):657-663. PubMed ID: 34075203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Readiness assessment for pragmatic trials (RAPT): a model to assess the readiness of an intervention for testing in a pragmatic trial.
    Baier RR; Jutkowitz E; Mitchell SL; McCreedy E; Mor V
    BMC Med Res Methodol; 2019 Jul; 19(1):156. PubMed ID: 31319789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pragmatic clinical trial design in emergency medicine: Study considerations and design types.
    Gettel CJ; Yiadom MYAB; Bernstein SL; Grudzen CR; Nath B; Li F; Hwang U; Hess EP; Melnick ER
    Acad Emerg Med; 2022 Oct; 29(10):1247-1257. PubMed ID: 35475533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments.
    Saesen R; Depreytere K; Krupianskaya K; Langeweg J; Verheecke J; Lacombe D; Huys I
    BMC Med Res Methodol; 2023 Jun; 23(1):148. PubMed ID: 37355603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the relevance of randomised trials to primary care: a qualitative study investigating views towards pragmatic trials and the PRECIS-2 tool.
    Forbes G; Loudon K; Clinch M; Taylor SJC; Treweek S; Eldridge S
    Trials; 2019 Dec; 20(1):711. PubMed ID: 31829266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the Explanatory or Pragmatic Nature of Cardiovascular Clinical Trials Over 2 Decades.
    Sepehrvand N; Alemayehu W; Das D; Gupta AK; Gouda P; Ghimire A; Du AX; Hatami S; Babadagli HE; Verma S; Kashour Z; Ezekowitz JA
    JAMA Cardiol; 2019 Nov; 4(11):1122-1128. PubMed ID: 31473763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Multigene Pharmacogenetic Testing in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention.
    Dong OM; Wheeler SB; Cruden G; Lee CR; Voora D; Dusetzina SB; Wiltshire T
    Value Health; 2020 Jan; 23(1):61-73. PubMed ID: 31952675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network.
    Ginsburg GS; Cavallari LH; Chakraborty H; Cooper-DeHoff RM; Dexter PR; Eadon MT; Ferket BS; Horowitz CR; Johnson JA; Kannry J; Kucher N; Madden EB; Orlando LA; Parker W; Peterson J; Pratt VM; Rakhra-Burris TK; Ramos MA; Skaar TC; Sperber N; Steen-Burrell KA; Van Driest SL; Voora D; Wiisanen K; Winterstein AG; Volpi S;
    Genet Med; 2021 Jul; 23(7):1185-1191. PubMed ID: 33782552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.
    Dal-Ré R
    Eur J Clin Pharmacol; 2021 Apr; 77(4):539-546. PubMed ID: 33106910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating pragmatic and implementation science randomized clinical trial approaches: a PRagmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) analysis.
    Zatzick D; Palinkas L; Chambers DA; Whiteside L; Moloney K; Engstrom A; Prater L; Russo J; Wang J; Abu K; Iles-Shih M; Bulger E
    Trials; 2023 Apr; 24(1):288. PubMed ID: 37085877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
    Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
    Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.